Evidence map›Paper›PMID 35813975›Full record

ArticleJournal of Ayurveda and integrative medicine

A case report of moderate COVID 19 patient managed through integrative approach (Siddha and conventional medicine).

B Neethi, P Shanmugapriya, G Janaranjani, S Gokila, B Prathisha, J K Jayasree

Abstract readCase Reports
In one paragraph

Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

B NeethiDept. of Nanju Maruthuvam, National Institute of Siddha, Chennai, India. Electronic address: neethi.nthi@gmail.com.
P ShanmugapriyaDept. of Nanju Maruthuvam, National Institute of Siddha, Chennai, India.
G JanaranjaniDept. of Nanju Maruthuvam, National Institute of Siddha, Chennai, India.
S GokilaDept. of Nanju Maruthuvam, National Institute of Siddha, Chennai, India.
B PrathishaDept. of Nanju Maruthuvam, National Institute of Siddha, Chennai, India.
J K JayasreeDept. of Nanju Maruthuvam, National Institute of Siddha, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: COVID 19 is a rapidly spreading disease with high mortality and morbidity all over the world which is caused by SARS-COV-2. Siddha system has various formulations with antiviral properties. The study is aimed at evaluating the efficacy of Siddha integrated with conventional medicine for effective management of COVID 19. Case summary: A 61 year old male patient diagnosed with COVID was brought in with the complaints of fever, cough, loss of smell, taste, tiredness and breathlessness after 7 days of infection. History revealed that he has not taken any treatment for the past 7 days and therefore presented with pneumonia at the time of consultation. Laboratory investigations showed Neutrophilia, Lymphocytopenia, raised NLR ratio, elevated CRP and D-Dimer. CT chest revealed CORADS-5 and severity score was 10/25. The patient was treated with Siddha medicine from 8 th Day. The patient had taken conventional treatment on 12 th day for 3 days only. Patient showed good improvement on 23 rd day and no adverse effect observed during the course of treatment. Conclusion: This case report demonstrates that moderate COVID 19 can be managed with integrative approach.

Indexed as

Case reportCOVID 19Integrative managementSiddha

Identifiers

PMID35813975
PMCPMC9250905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.